Literature DB >> 1353574

Response of cyclophosphamide-resistant Wegener's granulomatosis to etoposide.

D D'Cruz, H Payne, A Timothy, G R Hughes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1353574     DOI： 10.1016/0140-6736(92)91505-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

Review 1.  Clinical management and treatment of vasculitis.

Authors:  D Jayne
Journal:  Springer Semin Immunopathol       Date:  2001

Review 2.  Pulmonary vasculitis: classification, clinical features, and management.

Authors:  A Ciaccia; M Ferrari; F M Facchini; G Caramori; L Fabbri
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

3.  Immunosuppressive treatment in severe connective tissue diseases: effects of low dose intravenous cyclophosphamide.

Authors:  I Martin-Suarez; D D'Cruz; M Mansoor; A P Fernandes; M A Khamashta; G R Hughes
Journal:  Ann Rheum Dis       Date:  1997-08       Impact factor: 19.103

4.  Silent myocardial infarction in Wegener's granulomatosis.

Authors:  T Papo; J C Piette; R Laraki; O Bletry; D L Huong; P Godeau
Journal:  Ann Rheum Dis       Date:  1995-03       Impact factor: 19.103
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.